Literature DB >> 27634765

The Emerging Role of B Cells in Tumor Immunity.

Peiling Tsou1, Hiroyuki Katayama1, Edwin J Ostrin1, Samir M Hanash2.   

Abstract

There is increasing evidence supporting a role for B cells in tumor immunology. Paraneoplastic syndromes occurring before a cancer diagnosis have pointed to the potential for harnessing the humoral immune response for early cancer detection. The presence of tumor-infiltrating B lymphocytes has been linked to a favorable clinical outcome in many types of cancers. However, B cells represent a heterogeneous population with functionally distinct subsets, and the balance among subtypes impacts tumor development. Here, we review recent findings related to B cells and to the humoral immune response in cancer and their translational significance. Cancer Res; 76(19); 5597-601. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27634765     DOI: 10.1158/0008-5472.CAN-16-0431

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  112 in total

Review 1.  FOXOs in cancer immunity: Knowns and unknowns.

Authors:  Youcai Deng; Fangjie Wang; Tiffany Hughes; Jianhua Yu
Journal:  Semin Cancer Biol       Date:  2018-01-05       Impact factor: 15.707

2.  Immunity against cancer cells may promote their proliferation and metastasis.

Authors:  Chih-Wei Lin; Jia Xie; Ding Zhang; Kyung Ho Han; Geramie Grande; Nicholas C Wu; Zhuo Yang; Kyungmoo Yea; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

3.  A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity.

Authors:  Diana Rasoulouniriana; Nadine Santana-Magal; Amit Gutwillig; Leen Farhat-Younis; Yariv Wine; Corey Saperia; Lior Tal; Haim Gutman; Alexander Tsivian; Ronen Brenner; Eiman Abu Bandora; Nathan E Reticker-Flynn; Peleg Rider; Yaron Carmi
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

4.  The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.

Authors:  Fereshteh Mehdipour; Mahboobeh Razmkhah; Zahra Faghih; Mandana Bagheri; Abdol-Rasoul Talei; Abbas Ghaderi
Journal:  Cell Oncol (Dordr)       Date:  2019-03-08       Impact factor: 6.730

5.  Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.

Authors:  Kristin J Lastwika; Julia Kargl; Yuzheng Zhang; Xiaodong Zhu; Edward Lo; David Shelley; Jon J Ladd; Wei Wu; Paul Kinahan; Sudhakar N J Pipavath; Timothy W Randolph; Melissa Shipley; Paul D Lampe; A McGarry Houghton
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

6.  Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas.

Authors:  Anne-Kathrin Hess; Korinna Jöhrens; Andre Zakarneh; Panagiotis Balermpas; Jens Von Der Grün; Claus Rödel; Wilko Weichert; Michael Hummel; Ulrich Keilholz; Volker Budach; Ingeborg Tinhofer
Journal:  Oncoimmunology       Date:  2019-05-25       Impact factor: 8.110

Review 7.  B cells and antibody production in melanoma.

Authors:  Jessica Da Gama Duarte; Janique M Peyper; Jonathan M Blackburn
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

Review 8.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

Review 9.  Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.

Authors:  Khinh Ranh Voong; Josephine Feliciano; Daniel Becker; Benjamin Levy
Journal:  Ann Transl Med       Date:  2017-09

10.  Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy.

Authors:  Carmine De Angelis; Chandandeep Nagi; Cliff C Hoyt; Linying Liu; Kristin Roman; Chichung Wang; Yi Zheng; Jamunarani Veeraraghavan; Vidyalakshmi Sethunath; Paolo Nuciforo; Tao Wang; Anna Tsimelzon; Sufeng Mao; Susan G Hilsenbeck; Meghana V Trivedi; Maria Letizia Cataldo; Anne Pavlick; Antonio C Wolff; Britta Weigelt; Jorge S Reis-Filho; Aleix Prat; Carolina Gutierrez; Charles Kent Osborne; Mothaffar F Rimawi; Rachel Schiff
Journal:  Clin Cancer Res       Date:  2019-10-25       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.